What is the recommended dose of Librium (chlordiazepoxide) for managing alcohol withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chlordiazepoxide (Librium) Dosing for Alcohol Withdrawal

For alcohol withdrawal, the recommended initial dose of Librium (chlordiazepoxide) is 50 to 100 mg orally, followed by repeated doses as needed until agitation is controlled, up to 300 mg per day, with subsequent reduction to maintenance levels. 1

Dosing Regimen Based on Withdrawal Severity

The dosage of chlordiazepoxide should be determined by the severity of withdrawal symptoms, which can be assessed using the CIWA-Ar scale:

CIWA-Ar Score Severity Recommended Approach
≤7 Mild Monitor, may not require medication
8-14 Moderate Initiate benzodiazepine treatment
≥15 Severe Aggressive benzodiazepine treatment, consider inpatient management [2]

Specific Dosing Protocol

  1. Initial phase (Day 1-2):

    • 50-100 mg orally every 4-6 hours as needed for the first 24 hours
    • Maximum daily dose: 300 mg 1
  2. Tapering phase (Days 3-5):

    • Gradually reduce dose by approximately 20-25% per day
    • Example taper schedule:
      • Day 3: 25-50 mg every 6 hours
      • Day 4: 25 mg every 6-8 hours
      • Day 5: 25 mg every 12 hours
  3. Discontinuation (Day 6-7):

    • Complete withdrawal of medication

Special Considerations

Hepatic Impairment

  • Important caution: Chlordiazepoxide should be avoided in patients with hepatic insufficiency due to risk of dose-stacking and prolonged sedation 3
  • In patients with liver disease, short-acting benzodiazepines such as oxazepam or lorazepam are preferred due to their more favorable pharmacokinetic profile 2
  • The delayed onset of action with chlordiazepoxide in liver disease can lead to accumulation of unmetabolized drug and subsequent conversion to long-acting metabolites (particularly demoxepam), resulting in profound and prolonged sedation 3

Elderly Patients

  • Lower doses are recommended: 5 mg, 2 to 4 times daily 1
  • Increased sensitivity to benzodiazepines and higher risk of adverse effects warrant this dose reduction

Monitoring and Adjustments

  • Assess withdrawal symptoms regularly using CIWA-Ar scale
  • Adjust dosing based on symptom control and sedation level
  • Monitor vital signs, particularly for respiratory depression
  • Ensure adequate hydration and nutritional support, including thiamine supplementation 2

Comparative Efficacy

  • Chlordiazepoxide (80 mg/day) has shown similar efficacy to lorazepam (8 mg/day) in treating uncomplicated alcohol withdrawal 4
  • Patients treated with chlordiazepoxide may require more adjuvant therapy to control withdrawal symptoms compared to lorazepam 5

Common Pitfalls to Avoid

  • Underdosing in severe withdrawal, which may lead to progression to delirium tremens
  • Failure to recognize hepatic impairment before initiating chlordiazepoxide
  • Not providing adequate nutritional support and thiamine supplementation
  • Abrupt discontinuation rather than gradual tapering
  • Prescribing benzodiazepines without addressing the underlying alcohol use disorder 2

Remember that while chlordiazepoxide is effective for managing alcohol withdrawal symptoms, it should be part of a comprehensive treatment approach that includes addressing the underlying alcohol use disorder through appropriate pharmacotherapy and psychosocial interventions once the acute withdrawal phase has resolved.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.